Page 51 - 南京医科大学学报自然科学版
P. 51

第42卷第9期           张馨予,颜月园,刘 刚,等. LC⁃MS/MS法同时测定大鼠血浆中来那度胺、伏立诺他和
                  2022年9月            地塞米松的浓度[J]. 南京医科大学学报(自然科学版),2022,42(09):1240-1245                  ·1245 ·


                    spray ionization tandem mass spectrometry[J]. J Chro⁃  [13] GEORG H,THOMAS N,ALOIS L. Lenalidomide in com⁃
                    matogr B Anal Technol Biomed Life Sci,2014,949/950:  bination with vorinostat and dexamethasone for the treat⁃

                    63-69                                              ment of relapsed/refractory peripheral T cell lymphoma
               [6] 刘    琳,刘志红. 糖皮质激素作用机制的研究进展[J].                     (PTCL):report of a phase Ⅰ/Ⅱ trial[J]. Ann Hematol,
                    肾脏病与透析肾移植杂志,2014,23(5):472-476                     2014,93:459-462
               [7] 邵森楠,魏志凤,夏玉凤. 桑色素对地塞米松大鼠体内                     [14] 龚伟玲,荆凡波,曹        玉,等. 高效液相色谱法测定大鼠

                    药代动力学影响的研究[J]. 时珍国医国药,2019,30                      血浆中来那度胺的浓度及其药动学[J]. 现代生物医学
                    (12):2817-2819                                     进展,2014,14(20):3810-3814
               [8] CAVO M,TACCHETTI P,PATRIARCA F,et al. Bortezo⁃  [15] 罗莉娅,邓    星,苟立平,等. UPLC⁃MS/MS法研究来那
                    mib with thalidomide plus dexamethasone compared with  度胺在小鼠体内的组织分布[J]. 中国临床药理学杂
                    thalidomide plus dexamethasone as induction therapy be⁃  志,2019,35(14):1505-1509
                    fore,and consolidation therapy after,double autologous  [16] 刘  颖,朱凤昌,张华吉,等. LC⁃MS/MS 法定量测定马
                    stem⁃cell transplantation in newly diagnosed multiple mye⁃  血浆中地塞米松浓度的研究[J]. 中国药物评价,2017,
                    loma:a randomised phase 3 study[J]. Lancet,2010,376  34(4):252-254
                    (9758):2075-2085                             [17] 梅亚君,秦永平,章        丽,等. 高效液相色谱⁃串联质谱
               [9] KUMAR S K,BERDEJA J G,NIESVIZKY R,et al. Safe⁃      法测定人血清中伏立诺他及其 M2 代谢物浓度[J]. 华
                    ty and tolerability of ixazomib,an oral proteasome inhibi⁃  西医学,2016,31(2):278-282
                    tor,in combination with lenalidomide and dexamethasone  [18] 韩晓红,李  宁,宋媛媛,等. UPLC⁃MS/MS法测定人血
                    in patients with previously untreated multiple myeloma:  浆中伏立诺他的浓度及其药代动力学研究[J]. 药物分
                    an open⁃label phase 1/2 study[J]. Lancet Oncol,2014,15  析杂志,2014,34(9):1530-1535
                    (13):1503-1512                               [19] LI T X,HU L,ZHANG M M,et al. A sensitive UPLC⁃MS/
               [10] GHOSH N,TUCKER N,ZAHURAK M,et al. Clarithro⁃       MS method for simultaneous determination of eleven bio⁃
                    mycin overcomes resistance to lenalidomide and dexa⁃  active components of Tong⁃Xie⁃Yao⁃Fang decoction in rat
                    methasone in multiple myeloma[J]. Am J Hematol,2014,  biological matrices[J]. J Chromatogr,2014,944:90-
                    89(8):E116-E120                                    100
               [11] BAZ R C,SHAIN K H,HUSSEIN M A,et al. Phase Ⅱ  [20] 李天雪,胡玉涛,韦        笑,等. UPLC⁃MS 法同时定量大
                    study of pegylated liposomal doxorubicin,low⁃dose dexa⁃  鼠血浆中加味四逆散的6种有效成分[J]. 分析科学学
                    methasone,and lenalidomide in patients with newly diag⁃  报,2018,34(4):533⁃538
                    nosed multiple myeloma[J]. Am J Hematol,2014,89(1):  [21] US DEPARTMENT OF HEALTH AND HUMAN SER⁃
                    62-67                                              VICES FOOD AND DRUG ADMINISTRATION. Guid⁃
               [12] SIEGEL D S,P RICHARDSON,M DIMOPOULOS. Vori⁃        ance for industry,bioanalytical method validation[EB/OL].
                    nostat in combination with lenalidomi and dexamethasone  (2001⁃05⁃11)[2021⁃12⁃7]. http://www.ich.org
                    in patients with relapsed or refractory multiple myeloma                [收稿日期] 2021-12-17
                    [J]. Blood Cancer J,2014,4:182-188                                          (本文编辑:陈汐敏)
   46   47   48   49   50   51   52   53   54   55   56